コンテンツへスキップ
Merck
  • Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection.

Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection.

Cell host & microbe (2018-03-16)
Jarrod S Johnson, Sasha Y Lucas, Lynn M Amon, Stephanie Skelton, Rodolfo Nazitto, Sara Carbonetti, D Noah Sather, Dan R Littman, Alan Aderem
要旨

Myeloid dendritic cells (DCs) have the innate capacity to sense pathogens and orchestrate immune responses. However, DCs do not mount efficient immune responses to HIV-1, primarily due to restriction of virus reverse transcription, which prevents accumulation of viral cDNA and limits its detection through the cGAS-STING pathway. By allowing reverse transcription to proceed, we find that DCs detect HIV-1 in distinct phases, before and after virus integration. Blocking integration suppresses, but does not abolish, activation of the transcription factor IRF3, downstream interferon (IFN) responses, and DC maturation. Consistent with two stages of detection, HIV-1 "primes" chromatin accessibility of innate immune genes before and after integration. Once primed, robust IFN responses can be unmasked by agonists of the innate adaptor protein, MyD88, through a process that requires cGAS, STING, IRF3, and nuclear factor κB. Thus, HIV-1 replication increases material available for sensing, and discrete inflammatory inputs tune cGAS signaling to drive DC maturation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
タプシガルギン, ≥98% (HPLC), solid film
Sigma-Aldrich
Resiquimod, ≥98% (HPLC)
Sigma-Aldrich
MISSION® pLKO.1-puro 非哺乳shRNAコントロールプラスミドDNA, Targets no known mammalian genes
Sigma-Aldrich
エチレンジアミン四酢酸 二ナトリウム塩 溶液, for molecular biology, 0.5 M in H2O, DNase, RNase, NICKase and protease, none detected
Sigma-Aldrich
Amprenavir, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human IFI16
Sigma-Aldrich
MISSION® esiRNA, targeting human IRF3